About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 64255 record(s)
Req # A-2019-001634
On August 30, 2019 Health Canada was sent an application for approval of a Class 3 Cryotherapy device. Provide all possible details regarding the application and results.Organization: Health Canada
April 2020
Req # A-2019-001749
Copy of Natural Health Products Ingredients Database (NHPID) Issue Form submission and all the related records and reports used to substantiate the safety, efficacy and/or quality of the chemical substance Polylactic acid-glycolic acid copolymer as an encapsulating agent.Organization: Health Canada
April 2020
Req # A-2019-001653
Adverse Reaction Report (AER) for PSEUDOEPHEDRINE HYDROCHLORIDE. Report number: E2B_02601741.Organization: Health Canada
April 2020
Req # A-2019-001772
Advise whether the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review on August 2017 has received either: Notice of Deficiency (NOD); Notice of Non-Compliance (NON); NOD-Withdrawal (NOD-W) or NON-Withdrawal (NON-W).Organization: Health Canada
April 2020
Req # A-2019-001774
Copy of any Screening Acceptance Letters sent by Health Canada to the sponsor of the submission in relation to the attached Notice of Non-Compliance dated June 10, 2019.Organization: Health Canada
April 2020
Req # A-2019-001858
All records which went into the decision to implement of sex/gender tracking for medical device incidents which began in February 2020.Organization: Health Canada
April 2020
Req # A-2019-001859
Copy of public releases of all recalls, advisories or alerts of health products (drugs and medical devices) for the past twenty years which indicate particular risks to women or females.Organization: Health Canada
April 2020
Req # A-2019-001973
All documents on occupational health and safety done relating to the condition of the building interior, exterior, outside grounds, drainage, water wells and ground water created between 1972 to March 2, 2020 pertaining to the RCMP training facility previously located at Kemptville, Ontario.Organization: Health Canada
April 2020
Req # A-2019-001656
Adverse Reaction Report (AER) for TRIAMCINOLONE ACETONIDE. Report numbers: E2B_02116628, E2B_02305711, E2B_02329661, E2B_02421274, E2B_02446830, 000724367.Organization: Health Canada
April 2020
Req # A-2019-001982
The list of complaints and copies of the violation or non-compliance notices over the last five years: Company: BOULART INC. (Quebec Business Number (NEQ): 1163837975), 1355 32nd Avenue, Montreal, Quebec, H8T 3H2; Company: 9166-2387 QUÉBEC INC. (NEQ: 1163544688), 1355 32nd Avenue, Montreal, Quebec, H8T 3H2.Organization: Health Canada
April 2020